Dudediligence.

Insight Molecular Diagnostics Inc

IMDXNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$115,000Sep ’24$1.5MDec ’24$2.1MMar ’25$518,000Jun ’25$260,000Sep ’25$1.1MDec ’25$32,000Mar ’26$239,000Jun ’26
Net income, by quarter
−$13.5MSep ’24−$33.5MDec ’24−$6.7MMar ’25−$9.7MJun ’25−$10.9MSep ’25−$23.0MDec ’25−$4.3MMar ’26−$11.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$2.2M$958,000$1.5M$1.9M$4.1M
Gross profit$1.4M−$18,000$413,000$740,000$2.3M
Operating income−$53.7M−$18.0M−$25.1M−$61.0M−$51.1M
Net income−$64.1M−$72.9M−$27.8M−$60.7M−$50.2M
Operating cash flow−$35.9M−$45.6M−$23.3M−$20.7M−$22.2M
Free cash flow−$38.2M−$49.9M−$23.6M−$21.2M−$25.4M
Cash$32.9M$20.0M$9.4M$8.6M$11.6M
Shares outstanding92.2M5.9M8.3M17.5M28.7M